90 Views | 55 Downloads
April P. Carson, apcarson@uab.edu
G.M. conceptualized the study, performed statistical analysis, interpreted the data, and drafted the manuscript. D.L.L. performed statistical analysis, interpreted the data, and critically revised the manuscript. S.E.J., B.M.K., and A.P.C. conceptualized the study, interpreted the data, and critically revised the manuscript. M.R.I., D.T.L., M.M.S., D.A.L., V.J.H., G.H., J.D.R., J.H.V., D.O.K., A.A., and J.F.M. interpreted the data and critically revised the manuscript. A.P.C. is the guarantor of this work and, as such, had full access to all of the data and takes responsibility for the integrity of the data and the accuracy of the data analysis.
The authors thank the other investigators, the staff, and the participants of the REGARDS Study for the valuable contributions. A complete list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org.
M.M.S. and A.P.C. receive investigator-initiated research support from Amgen Inc. D.A.L. has been a consultant for the University of California, San Francisco (event adjudicator for Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke trial). No other potential conflicts of interest relevant to this article were reported.
This research project is supported by a National Institute of Neurological Disorders and Stroke, National Institutes of Health, and Department of Health and Human Services cooperative agreement U01-NS-041588. Additional support was provided by Centers for Disease Control and Prevention cooperative agreement U01-DP-006302.
© 2019 by the American Diabetes Association.